CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Agreement ended
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- CT ORDER Other Confidential Order
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 19 of 33 · 650 filings